Background: Despite the high burden of hepatitis B virus (HBV) infection in sub-Saharan Africa (SSA), a lack of access to widespread screening or treatment leads to most people remaining undiagnosed until later stages of disease when prognosis is poor and treatment options are limited. We evaluated the cost-effectiveness of community-based screening and early treatment with antiviral therapy for HBV in The Gambia. Methods: An economic evaluation comparing adult community-based screening using a Hepatitis B surface antigen (HBsAg) rapid test and subsequent HBV antiviral therapy to a status quo scenario, where no treatment is available, was performed by combining a decision tree with a Markov state transition model. This was parameterised wit...
BACKGROUND: Many people living with chronic HBV infection remain undiagnosed until l...
Background: Many people living with chronic HBV infection remain undiagnosed until later stages of d...
Background: Despite the introduction of immunisation for hepatitis B virus (HBV) in the 1990s, HBV-r...
Background: Despite the high burden of hepatitis B virus (HBV) infection in sub-Saharan Africa, abse...
SummaryBackgroundDespite the high burden of hepatitis B virus (HBV) infection in sub-Saharan Africa,...
Background Despite the high burden of hepatitis B virus (HBV) infection in sub-Saharan Africa, absen...
SummaryBackgroundDespite the high burden of hepatitis B virus (HBV) infection in sub-Saharan Africa,...
Background: Despite the high burden of hepatitis B virus (HBV) infection in sub-Saharan Africa, abse...
Background: Despite the high burden of hepatitis B virus (HBV) infection in sub-Saharan Africa, abse...
Background: Chronic hepatitis B infection is a significant cause of morbidity and mortality worldwid...
BACKGROUND: Chronic hepatitis B infection is a significant cause of morbidity and mortality worldwid...
Background: Chronic hepatitis B infection is a significant cause of morbidity and mortality worldwid...
Background: Chronic hepatitis B infection is a significant cause of morbidity and mortality worldw...
Erratum in :Correction to Lancet Glob Health 2016; 4: e568-78.Lancet Glob Health. 2016 Nov;4(11):e79...
Background: Many people living with chronic HBV infection remain undiagnosed until later stages of d...
BACKGROUND: Many people living with chronic HBV infection remain undiagnosed until l...
Background: Many people living with chronic HBV infection remain undiagnosed until later stages of d...
Background: Despite the introduction of immunisation for hepatitis B virus (HBV) in the 1990s, HBV-r...
Background: Despite the high burden of hepatitis B virus (HBV) infection in sub-Saharan Africa, abse...
SummaryBackgroundDespite the high burden of hepatitis B virus (HBV) infection in sub-Saharan Africa,...
Background Despite the high burden of hepatitis B virus (HBV) infection in sub-Saharan Africa, absen...
SummaryBackgroundDespite the high burden of hepatitis B virus (HBV) infection in sub-Saharan Africa,...
Background: Despite the high burden of hepatitis B virus (HBV) infection in sub-Saharan Africa, abse...
Background: Despite the high burden of hepatitis B virus (HBV) infection in sub-Saharan Africa, abse...
Background: Chronic hepatitis B infection is a significant cause of morbidity and mortality worldwid...
BACKGROUND: Chronic hepatitis B infection is a significant cause of morbidity and mortality worldwid...
Background: Chronic hepatitis B infection is a significant cause of morbidity and mortality worldwid...
Background: Chronic hepatitis B infection is a significant cause of morbidity and mortality worldw...
Erratum in :Correction to Lancet Glob Health 2016; 4: e568-78.Lancet Glob Health. 2016 Nov;4(11):e79...
Background: Many people living with chronic HBV infection remain undiagnosed until later stages of d...
BACKGROUND: Many people living with chronic HBV infection remain undiagnosed until l...
Background: Many people living with chronic HBV infection remain undiagnosed until later stages of d...
Background: Despite the introduction of immunisation for hepatitis B virus (HBV) in the 1990s, HBV-r...